BA
SRPT icon

BlackRock Advisors’s Sarepta Therapeutics SRPT Stock Holding History

BlackRock Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$25.7M Buy
938,370
+98,442
+12% +$3.95M 0.03% 465
2016
Q3 		$51.6M Buy
839,928
+697,122
+488% +$21.1M 0.05% 311
2016
Q2 		$2.72M Buy
142,806
+108,221
+313% +$2M ﹤0.01% 1325
2016
Q1 		$675K Sell
34,585
-23,877
-41% -$417K ﹤0.01% 1943
2015
Q4 		$2.25M Sell
58,462
-586,557
-91% -$19M ﹤0.01% 1363
2015
Q3 		$20.7M Buy
645,019
+20,973
+3% +$712K 0.02% 507
2015
Q2 		$19M Buy
624,046
+18,837
+3% +$385K 0.02% 539
2015
Q1 		$8.04M Buy
605,209
+231,546
+62% +$3.09M 0.01% 854
2014
Q4 		$5.41M Buy
373,663
+350,567
+1,518% +$5.94M 0.01% 953
2014
Q3 		$487K Sell
23,096
-97,225
-81% -$2.19M ﹤0.01% 1998
2014
Q2 		$3.58M Buy
120,321
+94,764
+371% +$3M ﹤0.01% 1041
2014
Q1 		$614K Buy
25,557
+1,355
+6% +$34.5K ﹤0.01% 1911
2013
Q4 		$493K Buy
24,202
+4,125
+21% +$123K ﹤0.01% 2054
2013
Q3 		$948K Buy
20,077
+1,143
+6% +$44K ﹤0.01% 1458
2013
Q2 		$720K Buy
+18,934
New +$677K ﹤0.01% 1558

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock Advisors's SRPT Position: Q4 2016 in Review

BlackRock Advisors increased its Sarepta Therapeutics (SRPT) stake by 12% in Q4 2016, buying an estimated $3.95M and bringing the position to 938,370 shares worth $25.7M. The position accounts for 0.03% of the portfolio, ranked #465.

BlackRock Advisors first reported a position in SRPT in Q2 2013 and has held it in 15 quarters since. The position peaked at $51.6M in Q3 2016. 177 funds tracked by Wall St. Rank hold SRPT as of Q4 2016.

  • BlackRock Advisors held 938,370 shares of Sarepta Therapeutics worth $25.7M as of Q4 2016.
  • BlackRock Advisors bought 98,442 Sarepta Therapeutics shares in Q4 2016, an estimated $3.95M.
  • Sarepta Therapeutics made up 0.03% of BlackRock Advisors's portfolio in Q4 2016, its #465 holding.
  • BlackRock Advisors first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Sarepta Therapeutics position peaked at $51.6M in Q3 2016.
  • 177 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.